COMMUNIQUÉS West-GlobeNewswire

Eton Pharmaceuticals Submits New Drug Application for DS-200
14/03/2019
FDA Previously Granted DS-200 Fast Track Designation DEER PARK, Ill., March 14, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), today announced that the Company has submitted a New Drug Application ( [...]
electroCore Announces Encouraging Research Supporting Key Areas of Clinical Development for its Non-Invasive Vagus Nerve Stimulator, gammaCore™
14/03/2019
Data presented at the 3rd International Brain Stimulation Conference support the use of nVNS for treatment of mild traumatic brain injury and rheumatoid arthritis BASKING RIDGE, N.J., March 14, 2019 (GLOBE NEWSWIRE) -- [...]
iCAD to Present Corporate Overview at the 31st Annual ROTH Conference
14/03/2019
NASHUA, N.H., March 14, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chief [...]
Gala Pharmaceutical Starts Construction of Its Long Beach California Testing Facility
14/03/2019
IRVINE, Calif., March 14, 2019 (GLOBE NEWSWIRE) -- IRVINE, Calif., March 13, 2019 (GLOBE NEWSWIRE) -- Gala Pharmaceutical, Inc. ( GLPH ), a provider of cannabis testing in Southern California, today announced that it [...]
Cue Biopharma to Present Corporate Overview and Update at the Oppenheimer 29th Annual Healthcare Conference
14/03/2019
CAMBRIDGE, Mass., March 14, 2019 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ: CUE) an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the [...]
Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2018 Financial Results and Business Update
14/03/2019
AZEDRA ® (iobenguane I 131) U.S. Commercial Launch – 14 Treatment Requests from Patients Have Been Received and Scheduling for those Patients is Underway; 8 Centers Throughout the U.S. are Ready to Treat Patients [...]
Progenics Asserts Ownership of PSMA-617 Intellectual Property, Including Composition of Matter Patent
14/03/2019
NEW YORK, March 14, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company focused on the development and commercialization of innovative targeted medicines and artificial [...]
Radient Technologies Inc. Announces Commencement of Production of Cannabis Extracts at Commercial Scale
14/03/2019
EDMONTON, Alberta, March 14, 2019 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ) is pleased to announce that it has begun production of cannabis extracts at [...]
Auris Medical Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results
14/03/2019
Phase 1 trial confirmed superior bioavailability of intranasal betahistine as well as good safety and tolerability Intranasal betahistine program progressing towards proof-of-concept studies in acute vertigo (AM-125) [...]
Emerald Health Therapeutics Continues to Grow Sales with First Cannabis Shipment to Ontario Cannabis Retail Corporation
14/03/2019
Ontario marks a key province to offer Emerald-branded cannabis products, expanding Emerald’s market opportunity to over half of the Canadian cannabis-consuming population VICTORIA, British Columbia, March 14, 2019 ( [...]
Kamada Awarded the Israeli Outstanding Exporter Award for 2017
14/03/2019
Company received the award from the Israeli Minister of Economy and Industry for its growing export revenues For fiscal 2017, Kamada's total revenues were $102.8 Million, an increase of more than 33% compared to 2016. [...]
Summit Highlights Use of Discuva Platform in Identifying New Mechanism Antibiotics against Neisseria Gonorrhoeae and ESKAPE Pathogens at Novel Antimicrobials and AMR Diagnostics 2019 Conference
14/03/2019
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Highlights Use of Discuva Platform in Identifying New Mechanism Antibiotics against Neisseria Gonorrhoeae and ESKAPE Pathogens at Novel Antimicrobials and AMR [...]
ContraFect Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
14/03/2019
YONKERS, N.Y., March 14, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of novel, differentiated biologic therapeutics for [...]
Aleafia Health and Emblem Announce Closing of Arrangement
14/03/2019
TORONTO, March 14, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“ Aleafia Health ”) and Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“ Emblem ”) are pleased to announce that they have [...]
Axsome Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
14/03/2019
Company to host conference call today at 8:00 AM Eastern NEW YORK, March 14, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for [...]
Axovant Sciences Announces Pricing of $40 Million Public Offering of Common Shares
14/03/2019
NEW YORK and BASEL, Switzerland, March 14, 2019 (GLOBE NEWSWIRE) -- Axovant Sciences (Nasdaq: AXGT) ("Axovant") today announced the pricing of its underwritten public offering of 26,666,667 of its common shares at a [...]
Neos Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results
14/03/2019
- New commercial strategy including optimized salesforce structure, new distribution network and focus on improving net margins expected to accelerate path to profitability – - Company to host conference call today at 8 [...]
Rockwell Medical, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results
14/03/2019
– Company is poised to advance multiple formulations of Triferic®, the first and only FDA-approved therapy indicated to replace iron and maintain hemoglobin levels in adult hemodialysis patients – WIXOM, Mich., March 14 [...]
Medtronic Board Appoints Andrea J. Goldsmith, Ph.D. as a New Director
14/03/2019
DUBLIN - March 14, 2019 - Medtronic plc (NYSE:MDT) today announced that its Board of Directors has appointed Andrea J. Goldsmith, Ph.D. to the Board as an independent director, effective March 11, 2019. Dr. Goldsmith is [...]

Pages